272 related articles for article (PubMed ID: 11150284)
1. Iris melanoma: risk factors for metastasis in 169 consecutive patients.
Shields CL; Shields JA; Materin M; Gershenbaum E; Singh AD; Smith A
Ophthalmology; 2001 Jan; 108(1):172-8. PubMed ID: 11150284
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with elevated intraocular pressure in eyes with iris melanoma.
Shields CL; Materin MA; Shields JA; Gershenbaum E; Singh AD; Smith A
Br J Ophthalmol; 2001 Jun; 85(6):666-9. PubMed ID: 11371484
[TBL] [Abstract][Full Text] [Related]
3. Iris melanoma: features and prognosis in 317 children and adults.
Shields CL; Kaliki S; Shah SU; Luo W; Furuta M; Shields JA
J AAPOS; 2012 Feb; 16(1):10-6. PubMed ID: 22370659
[TBL] [Abstract][Full Text] [Related]
4. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
[TBL] [Abstract][Full Text] [Related]
5. Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide.
Shields CL; Kaliki S; Hutchinson A; Nickerson S; Patel J; Kancherla S; Peshtani A; Nakhoda S; Kocher K; Kolbus E; Jacobs E; Garoon R; Walker B; Rogers B; Shields JA
Ophthalmology; 2013 Apr; 120(4):766-72. PubMed ID: 23290981
[TBL] [Abstract][Full Text] [Related]
6. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
[TBL] [Abstract][Full Text] [Related]
7. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
[TBL] [Abstract][Full Text] [Related]
8. Iris melanocytoma: clinical features and natural course in 47 cases.
Demirci H; Mashayekhi A; Shields CL; Eagle RC; Shields JA
Am J Ophthalmol; 2005 Mar; 139(3):468-75. PubMed ID: 15767055
[TBL] [Abstract][Full Text] [Related]
9. Diffuse iris melanoma: a report of 25 cases.
Demirci H; Shields CL; Shields JA; Eagle RC; Honavar SG
Ophthalmology; 2002 Aug; 109(8):1553-60. PubMed ID: 12153810
[TBL] [Abstract][Full Text] [Related]
10. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
Shields CL; Naseripour M; Shields JA; Freire J; Cater J
Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
[TBL] [Abstract][Full Text] [Related]
11. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
[TBL] [Abstract][Full Text] [Related]
12. Ring melanoma of the anterior chamber angle: a report of fourteen cases.
Demirci H; Shields CL; Shields JA; Eagle RC; Honavar S
Am J Ophthalmol; 2001 Sep; 132(3):336-42. PubMed ID: 11530045
[TBL] [Abstract][Full Text] [Related]
13. Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma.
Fabian ID; Thaung C; AlHarby L; Sisley K; Mudhar HS; Doherty RE; Stacey AW; Arora AK; Cohen VML; Sagoo MS
Am J Ophthalmol; 2017 Sep; 181():97-105. PubMed ID: 28673748
[TBL] [Abstract][Full Text] [Related]
14. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
15. Diffuse Anterior Retinoblastoma with Globe Salvage and Visual Preservation in 3 Consecutive Cases.
Shields CL; Lally SE; Manjandavida FP; Leahey AM; Shields JA
Ophthalmology; 2016 Feb; 123(2):378-384. PubMed ID: 26522706
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study.
Khan S; Finger PT; Yu GP; Razzaq L; Jager MJ; de Keizer RJ; Sandkull P; Seregard S; Gologorsky D; Schefler AC; Murray TG; Kivelä T; Giuliari GP; McGowan H; Simpson ER; Corriveau C; Coupland SE; Damato BE
Arch Ophthalmol; 2012 Jan; 130(1):57-64. PubMed ID: 21911649
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanomas of the iris.
Batioğlu F; Günalp I
Jpn J Ophthalmol; 1998; 42(4):281-5. PubMed ID: 9749868
[TBL] [Abstract][Full Text] [Related]
18. Iris metastasis from systemic cancer in 104 patients: the 2014 Jerry A. Shields Lecture.
Shields CL; Kaliki S; Crabtree GS; Peshtani A; Morton S; Anand RA; Coco G; Shields JA
Cornea; 2015 Jan; 34(1):42-8. PubMed ID: 25343701
[TBL] [Abstract][Full Text] [Related]
19. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
[TBL] [Abstract][Full Text] [Related]
20. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
